首页> 外国专利> A MARKER FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT, A KIT AND MICROARRAY COMPRISING THE SAME AND METHOD FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT USING THE MARKER

A MARKER FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT, A KIT AND MICROARRAY COMPRISING THE SAME AND METHOD FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT USING THE MARKER

机译:一种用于预测肝细胞癌患者生存期的标记物,一种套件和一种包含该标记物的微阵列,用于预测肝细胞癌患者的生存期

摘要

Markers for predicting survival period of a hepatocellular carcinoma patient is provided to identify genes capable of predicting survival period of a hepatocellular carcinoma patient after hepatectomy through analysis of cDNA(complementary DNA) microarray. A marker for predicting survival period of a hepatocellular carcinoma patient after hepatectomy is identified by binding Cy5-dUTP to cDNA prepared by performing reverse transcription of mRNA(messenger RNA) extracted from a hepatocellular carcinoma cell, binding Cy3-dUTP to cDNA prepared by performing reverse transcription of mRNA extracted from the placenta as a control, mixing cDNA of hepatocellular carcinoma cell with cDNA of placenta, hybridizing the mixture with a DNA microarray, and analyzing the hybridization results with a computer.
机译:提供了用于预测肝癌患者生存期的标记,以通过分析cDNA(互补DNA)微阵列来鉴定能够预测肝切除术后肝细胞癌患者生存期的基因。通过将Cy5-dUTP与从肝癌细胞提取的mRNA(信使RNA)进行反转录而制备的cDNA结合,并将Cy3-dUTP与通过逆转录而制备的cDNA结合,从而鉴定出预测肝切除术后肝细胞癌患者生存期的标志物。转录从胎盘提取的mRNA作为对照,将肝癌细胞的cDNA与胎盘的cDNA混合,将混合物与DNA微阵列杂交,并用计算机分析杂交结果。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号